6,013 research outputs found
A Unique Seasonal Pattern in Phytoplankton Biomass in Low-Latitude Waters in the South China Sea
A distinctive seasonal pattern in phytoplankton biomass was observed at the South East Asian Time series Study (SEATS) station (18°N, 116°E) in the northern South China Sea (SCS). Surface chlorophyll-a, depth integrated chlorophyll-a and primary production were elevated to 0.3 mg/m3, ~35 mg/m2 and 300 mg-C/m2/d, respectively, in the winter but stayed low, at 0.1 mg/m3, ~15 mg/m2 and 110 mg-C/m2/d as commonly found in other low latitude waters, in the rest of the year. Concomitantly, soluble reactive phosphate and nitrate+nitrite in the mixed layer also became readily detectable in the winter. The elevation of phytoplankton biomass coincided approximately with the lowest sea surface temperature and the highest wind speed in the year. Only the combined effect of convective overturn by surface cooling and wind-induced mixing could have enhanced vertical mixing sufficiently to make the nutrients in the upper nutricline available for photosynthetic activities and accounted for the higher biomass in the winter
Medium effect on photon production in ultrarelativistic nuclear collisions
The effect of in-medium vector and axial-vector meson masses on photon
production is studied. We assume that the effective mass of a vector meson in
hot nuclear matter decreases according to a universal scaling law, while that
of an axial-vector meson is given by Weinberg's mass formula. We find that the
thermal production rate of photons increases with reduced masses, and is
enhanced by an order of magnitude at T=160 MeV with MeV. Assuming
a hydrodynamic evolution, we estimate the effect of the reduced masses on
photon production in nucleus-nucleus collisions. The result is compared to
experimental data from the WA80/WA98 collaboration.Comment: 21 pages, REVTEX + 9 figures (ps file
A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation
Background: Nasopharyngeal carcinoma (NPC) is an epithelial malignancy strongly associated with Epstein-Barr virus (EBV). AT13387 is a novel heat shock protein 90 (Hsp90) inhibitor, which inhibits the chaperone function of Hsp90 and reduces expression of Hsp90-dependent client oncoproteins. This study aimed to evaluate both the in vitro and in vivo antitumor effects of AT13387 in the EBV-positive NPC cell line C666-1.Results: Our results showed that AT13387 inhibited C666-1 cell growth and induced cellular senescence with the downregulation of multiple Hsp90 client oncoproteins EGFR, AKT, CDK4, and restored the protein expression of negative cell cycle regulator p27. We also studied the ability of AT13387 to restore p27 expression by downregulation of AKT and the p27 ubiquitin mediator, Skp2, using AKT inhibitor and Skp2 siRNA. In the functional study, AT13387 inhibited cell migration with downregulation of a cell migration regulator, HDAC6, and increased the acetylation and stabilization of α-tubulin. We also examined the effect of AT13387 on putative cancer stem cells (CSC) by 3-D tumor sphere formation assay. AT13387 effectively reduced both the number and size of C666-1 tumor spheres with decreased expression of NPC CSC-like markers CD44 and SOX2. In the in vivo study, AT13387 significantly suppressed tumor formation in C666-1 NPC xenografts.Conclusion: AT13387 suppressed cell growth, cell migration, tumor sphere formation and induced cellular senescence on EBV-positive NPC cell line C666-1. Also, the antitumor effect of AT13387 was demonstrated in an in vivo model. This study provided experimental evidence for the preclinical value of using AT13387 as an effective antitumor agent in treatment of NPC. © 2013 Chan et al.; licensee BioMed Central Ltd.published_or_final_versio
Circulating leukocyte telomere length is highly heritable among families of Arab descent
Background
Telomere length, an indicator of ageing and longevity, has been correlated with several biomarkers of cardiometabolic disease in both Arab children and adults. It is not known, however, whether or not telomere length is a highly conserved inheritable trait in this homogeneous cohort, where age-related diseases are highly prevalent. As such, the aim of this study was to address the inheritability of telomere length in Saudi families and the impact of cardiometabolic disease biomarkers on telomere length.
Methods
A total of 119 randomly selected Saudi families (123 adults and 131 children) were included in this cross-sectional study. Anthropometrics were obtained and fasting blood samples were taken for routine analyses of fasting glucose and lipid profile. Leukocyte telomere length was determined using quantitative real time PCR.
Results
Telomere length was highly heritable as assessed by a parent-offspring regression [h2 = 0.64 (p = 0.0006)]. Telomere length was modestly associated with BMI (R2 0.07; p-value 0.0087), total cholesterol (R2 0.08; p-value 0.0033), and LDL-cholesterol (R2 0.15; p-value 3 x 10-5) after adjustments for gender, age and age within generation.
Conclusion
The high heritability of telomere length in Arab families, and the associations of telomere length with various cardiometabolic parameters suggest heritable genetic fetal and/or epigenetic influences on the early predisposition of Arab children to age-related diseases and accelerated ageing
Persistence of a Continuous Stochastic Process with Discrete-Time Sampling: Non-Markov Processes
We consider the problem of `discrete-time persistence', which deals with the
zero-crossings of a continuous stochastic process, X(T), measured at discrete
times, T = n(\Delta T). For a Gaussian Stationary Process the persistence (no
crossing) probability decays as exp(-\theta_D T) = [\rho(a)]^n for large n,
where a = \exp[-(\Delta T)/2], and the discrete persistence exponent, \theta_D,
is given by \theta_D = \ln(\rho)/2\ln(a). Using the `Independent Interval
Approximation', we show how \theta_D varies with (\Delta T) for small (\Delta
T) and conclude that experimental measurements of persistence for smooth
processes, such as diffusion, are less sensitive to the effects of discrete
sampling than measurements of a randomly accelerated particle or random walker.
We extend the matrix method developed by us previously [Phys. Rev. E 64,
015151(R) (2001)] to determine \rho(a) for a two-dimensional random walk and
the one-dimensional random acceleration problem. We also consider `alternating
persistence', which corresponds to a < 0, and calculate \rho(a) for this case.Comment: 14 pages plus 8 figure
Recommended from our members
Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach
Lung cancer can be classified into two main categories: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), which are different in treatment strategy and survival probability. The lung CT images of SCLC and NSCLC are similar such that their subtle differences are hardly visually discernible by the human eye through conventional imaging evaluation. We hypothesize that SCLC/NSCLC differentiation could be achieved via computerized image feature analysis and classification in feature space, as termed a radiomic model. The purpose of this study was to use CT radiomics to differentiate SCLC from NSCLC adenocarcinoma. Patients with primary lung cancer, either SCLC or NSCLC adenocarcinoma, were retrospectively identified. The post-diagnosis pre-treatment lung CT images were used to segment the lung cancers. Radiomic features were extracted from histogram-based statistics, textural analysis of tumor images and their wavelet transforms. A minimal-redundancy-maximal-relevance method was used for feature selection. The predictive model was constructed with a multilayer artificial neural network. The performance of the SCLC/NSCLC adenocarcinoma classifier was evaluated by the area under the receiver operating characteristic curve (AUC). Our study cohort consisted of 69 primary lung cancer patients with SCLC (n = 35; age mean ± SD = 66.91± 9.75 years), and NSCLC adenocarcinoma (n = 34; age mean ± SD = 58.55 ± 11.94 years). The SCLC group had more male patients and smokers than the NSCLC group (P \u3c 0.05). Our SCLC/NSCLC classifier achieved an overall performance of AUC of 0.93 (95% confidence interval = [0.85, 0.97]), sensitivity = 0.85, and specificity = 0.85). Adding clinical data such as smoking history could improve the performance slightly. The top ranking radiomic features were mostly textural features. Our results showed that CT radiomics could quantitatively represent tumor heterogeneity and therefore could be used to differentiate primary lung cancer subtypes with satisfying results. CT image processing with the wavelet transformation technique enhanced the radiomic features for SCLC/NSCLC classification. Our pilot study should motivate further investigation of radiomics as a non-invasive approach for early diagnosis and treatment of lung cancer
The EPL drama – paving the way for more illegal streaming? Digital piracy of live sports broadcasts in Singapore
Accuracy and cost-effectiveness of dynamic contrast-enhanced CT in the characterisation of solitary pulmonary nodules — the SPUtNIk study
Solitary pulmonary nodules (SPNs) are common on CT. The most cost-effective investigation algorithm is still to be determined. Dynamic contrastenhanced CT (DCE-CT) is an established diagnostic test not widely available in the UK currently.
The SPUtNIk study will assess the diagnostic accuracy, clinical utility and cost-effectiveness of DCE-CT, alongside the current CT and 18-flurodeoxyglucose-positron emission tomography) (FDG-PET)-CT nodule characterisation strategies in the National Health Service (NHS). Image acquisition and data analysis for FDG-PET-CT and DCE-CT will follow a standardised protocol with central review of 10% to ensure quality assurance. Decision analytic modelling will assess the likely costs and health outcomes resulting from incorporation of DCE-CT into management strategies for patients with SPNs.
Approval has been granted by the South West Research Ethics Committee. Ethics reference number 12/SW/0206. The results of the trial will be presented at national and international meetings and published in an Health Technology Assessment (HTA) Monograph and in peer-reviewed journals.The trial is funded by the National Institute for Health Research HTA Programme (grant no: 09/22/117) and is being run by Southampton Clinical Trials Unit, directed by Professor Gareth Griffiths and part funded by Cancer Research UK. NRQ and RCR are part funded by the Cambridge Biomedical Research Centre and the Cancer Research Network: Eastern
- …